monatepil has been researched along with Arteriosclerosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoki, K; Ikeno, A; Karasawa, T; Kato, H; Kurokawa, M; Masuda, Y; Minato, H; Yamada, T; Zushi, K | 1 |
| Nayler, WG | 1 |
| Miyazaki, M | 1 |
| Harano, Y; Koh, H; Kyotani, S; Nishioeda, Y; Omae, T; Suzuki, M; Tsushima, M; Waki, M | 1 |
| Hosoki, K; Ikeno, A; Ishii, K; Miyazaki, M; Okazaki, Y; Okunishi, H | 1 |
2 review(s) available for monatepil and Arteriosclerosis
| Article | Year |
|---|---|
New therapeutic trends in calcium antagonism. Are they meaningful?
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Dibenzothiepins; Humans; Piperazines | 1994 |
Antihypertensive, antiatherosclerotic, and plasma lipid-lowering effects of monatepil, a novel calcium antagonist with alpha 1-adrenoceptor-blocking activity in experimental animals.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Arteriosclerosis; Calcium Channel Blockers; Dibenzothiepins; Hypolipidemic Agents; Piperazines | 1994 |
3 other study(ies) available for monatepil and Arteriosclerosis
| Article | Year |
|---|---|
Inhibitory effect of the new calcium antagonist AJ-2615 on progression of atherosclerosis in cholesterol-fed rabbits.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Cholesterol, Dietary; Dibenzothiepins; Diltiazem; Male; Phospholipids; Piperazines; Prazosin; Rabbits; Triglycerides | 1993 |
Noninvasive quantitative evaluation of early atherosclerosis and the effect of monatepil, a new antihypertensive agent. An interim report.
Topics: Aged; Antihypertensive Agents; Aorta, Abdominal; Arteriosclerosis; Calcium Channel Blockers; Carotid Arteries; Cholesterol; Dibenzothiepins; Female; Humans; Hypercholesterolemia; Hypertension; Image Processing, Computer-Assisted; Male; Middle Aged; Piperazines; Tomography, X-Ray Computed; Ultrasonography, Doppler | 1994 |
Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Arteriosclerosis; Blood Pressure; Calcium Channel Blockers; Cholesterol, Dietary; Dibenzothiepins; Diet; Female; Heart Rate; Hypolipidemic Agents; Lipid Peroxidation; Lipids; Lipoproteins; Macaca; Male; Piperazines; Platelet Aggregation; Prazosin | 1994 |